Companies
Locus Fermentation Solutions
A global leader in sophorolipid precision fermentation, supplying the palm-oil-free, non-GMO Amphi line (USDA BioPreferred certified); the company raised over $40M in 2025 to expand capacity.
- Country
- United States
Coverage
| CN | EU | US | |
|---|---|---|---|
| specialty-fine-chem | ✓ | ✓ | ✓ |
Regulatorsepareachnmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | Over $250 million total funding raised as of 2024, with $40 million raised in 2025 | agfundernews.com · caplight.com · prnewswire.com |
| Capacity | Future capacity potential of 2.5 million kilograms of biosurfactants annually, with a 4x year-over-year increase as of 2026 | prnewswire.com |
| Certification | USDA Certified 100% Biobased Product; EPA Safer Choice certified | locusfs.com · stle.org · synbiobeta.com |
| Regulatory approval | Full Amphi line TSCA registered; REACH registered in the UK and Europe | locusfs.com · synbiobeta.com |
| Production site | Solon, Ohio (manufacturing and lab facilities); The Woodlands, Texas (laboratory operations); Midland (facility expansion) | locusfs.com · prnewswire.com |
Independent sources: agfundernews.com · caplight.com · locusfs.com · prnewswire.com · stle.org · synbiobeta.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biosurfactants | specialty-fine-chem | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.